by adminAdrianRamirez | Jan 6, 2017 | Axim Biotechnologies, Press Releases
SAN DIEGO, CA — (Marketwired) — 01/06/17 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first publicly traded cannabis company in the United States, today announced that the Company was featured in a recent High Times article, “10 Largest...
by adminAdrianRamirez | Jan 4, 2017 | Axim Biotechnologies, Press Releases
NEW YORK – Jan. 04, 2017 – AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, and gears up for clinical trial on alleviating...
by adminAdrianRamirez | Dec 28, 2016 | Axim Biotechnologies, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannalife Sciences, Kannaway, Press Releases
Company Releases Recap Report of Activities in 2016 and Announces Excitement for Coming Year SAN DIEGO, CA — (Marketwired) — 12/28/16 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States,...
by adminAdrianRamirez | Dec 13, 2016 | Axim Biotechnologies, Dixie Botanicals, Kannaway, Press Releases
Article Features Positive Growth Stats for the CBD Market and Information on Medical Marijuana, Inc. Products, Investments and Subsidiary Companies SAN DIEGO, CA–(Marketwired – December 13, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA), the...
by adminAdrianRamirez | Nov 30, 2016 | Axim Biotechnologies, Company News, Media Coverage
Despite troubles among most biotech companies this past year, some companies, like AXIM® Biotechnologies, were able to capitalize on market positioning, new innovations, and investor excitement to make major stock price gains. Medical Marijuana, Inc. investment...